• PD0325901: From MEK Inhibition to TERT Chromatin

  2026-08-23

  PD0325901 is a selective MEK inhibitor that connects RAS/RAF/MEK/ERK signaling with cell-state and chromatin readouts. This guide uses TERT regulation in human pluripotent stem cells to develop a more discriminating assay strategy than pathway inhibition alone.

• Acetoacetic Acid Sodium Salt: Assay Workflows

  2026-08-22

  Build reproducible ketone-body assays with Acetoacetic acid sodium salt, from fresh aqueous standards to matrix-aware LC-MS or enzymatic readouts. The workflow connects diabetes metabolic imbalance and fatty acid catabolism pathway studies with practical controls, stability safeguards, and isotope-informed analytical design.

• USP7–PKM2 Control of Macrophage Polarization

  2026-08-21

  The 2025 Cell Death and Disease study identifies USP7 as an upstream regulator of PKM2-dependent metabolic reprogramming in macrophages during severe acute pancreatitis. By combining genetic, metabolic, biochemical, and pharmacological experiments, the authors connect USP7-mediated PKM2 deubiquitination with M1 polarization and pancreatic inflammation, providing a mechanistic framework for targeting immunometabolism in SAP.

• (S)-(+)-Dimethindene maleate: M2 Workflow

  2026-08-21

  This practical guide explains how (S)-(+)-Dimethindene maleate can support receptor-selectivity profiling involving M2 muscarinic and H1 histamine receptors, with emphasis on solution handling, controls, and interpretation. It is a research reagent only; the available dossier does not establish clinical, diagnostic, or directly matched paper outcomes.

• One-step TUNEL Cy5: From Breaks to Biology

  2026-08-20

  The One-step TUNEL Cy5 Apoptosis Detection Kit reveals DNA fragmentation while preserving the biological context needed for stronger apoptosis conclusions. This guide connects TUNEL assay kit design with TBK1–IRG1–itaconate immunometabolism, controls, and quantitative interpretation.

• ECL Western Blotting Substrate: HRP Guide

  2026-08-20

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence in Western blot assays. It is intended for HRP-based immunoblot workflows using X-ray film or CCD imaging, not fluorescent or radioisotopic detection protocols.

• Exo1 for Acute Membrane-Trafficking Studies

  2026-08-19

  Exo1, or methyl 2-(4-fluorobenzamido)benzoate, enables acute dissection of Golgi–ER traffic and exocytosis. This article connects its ARF1-selective phenotype with assay design and explains how it can, with appropriate controls, inform tumor extracellular vesicle research without overstating the evidence.

• Niclosamide: From Pathway Assay to Evidence

  2026-08-19

  Niclosamide is a STAT3-focused research compound whose value depends on matching mechanism, endpoint, and exposure context. This article connects cancer research assays with field-toxicity evidence to clarify what the data support—and what they do not.

• Topotecan: From DNA Damage to Assay Meaning

  2026-08-18

  Topotecan (SKF104864) is examined here as a mechanistic perturbation tool rather than merely a cytotoxic compound. This guide connects topoisomerase I biology, assay interpretation, translational model selection, and lessons from a radiotracer study in ulcerative colitis research.

• PYR-41 for E1 and Ubiquitination Research

  2026-08-17

  Use PYR-41 to connect E1-dependent ubiquitin activation with protein stability, IRF7 antiviral signaling, and inflammatory readouts. This workflow emphasizes dose control, orthogonal validation, and the distinction between pathway discovery and therapeutic interpretation.

• Dihydroquercetin, IPEC-J2 Proliferation, and Wnt Signaling

  2026-08-17

  The reference study identifies dihydroquercetin as a promoter of porcine intestinal epithelial cell proliferation and links this effect to Wnt/β-catenin signaling. Its combination of proliferation, tight-junction, gene-expression, and inhibitor-based analyses provides a useful mechanistic framework for studying intestinal barrier support in vitro.

• Lypressin Acetate: Mechanism and Research Use

  2026-08-16

  Lypressin acetate, also called Lysine vasopressin acetate, is a lysine-substituted vasopressin analog with V1a, V1b, and V2 receptor agonism. Its antidiuretic and vasopressor profiles support diabetes insipidus research, receptor pharmacology, and carefully separated exploratory antiviral studies.

• Toremifene and the Metastatic Signaling Gap

  2026-08-15

  Toremifene offers translational researchers a way to interrogate estrogen receptor biology while connecting hormone-responsive phenotypes with emerging calcium-signaling mechanisms in prostate cancer. This article outlines how to position the compound in rigorous in vitro and in vivo workflows without overstating its relationship to the TSPAN18–STIM1 axis.

• Fucoidan, Irinotecan, and the Gut–Liver Axis

  2026-08-15

  The reference study identifies intestinal barrier failure and hepatic neutrophil extracellular traps as a linked mechanism of irinotecan-induced steatohepatitis. Its mouse experiments suggest that fucoidan can reduce liver injury by preserving gut barrier function, limiting lipopolysaccharide translocation, and suppressing excessive NET formation.

• DAPI (hydrochloride) for DNA Analysis

  2026-08-14

  Build reproducible workflows for chromosome staining, cell-cycle profiling, and nuclear analysis with DAPI (hydrochloride). This guide also shows how a DNA readout can complement erythrocyte-mimicking nanovesicle studies without being mistaken for a bacterial-specific or photodynamic endpoint.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page